CSCO

Cisco Showcases New Product Innovations Centered Around AI, Security and Observability at the 28th Annual Cisco Partner Summit

Retrieved on: 
Tuesday, November 7, 2023

MIAMI BEACH, Fla., Nov. 7, 2023 /PRNewswire/ -- CISCO PARTNER SUMMIT -- Cisco (NASDAQ: CSCO) Partner Summit 2023 begins today, bringing together thousands of Cisco partners from around the world to network, learn and celebrate their shared successes with Cisco. Around 90 percent of Cisco's revenue flows through Cisco's partners, represented by tens of thousands of organizations from more than 150 countries.

Key Points: 
  • New Cisco Security Suites — User, Cloud, and Breach Protection Suites — offer a simplified, integrated, and economical way to buy and consume Cisco's security solutions.
  • Cisco launches observability ecosystem — enabling organizations to create new modules on the Cisco Observability Platform.
  • MIAMI BEACH, Fla., Nov. 7, 2023 /PRNewswire/ -- CISCO PARTNER SUMMIT -- Cisco (NASDAQ: CSCO) Partner Summit 2023 begins today, bringing together thousands of Cisco partners from around the world to network, learn and celebrate their shared successes with Cisco.
  • Cisco Partner Summit 2023 begins today, bringing together thousands of Cisco partners.

SPLUNK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Splunk Inc. - SPLK

Retrieved on: 
Wednesday, November 1, 2023

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Splunk Inc. (NasdaqGS: SPLK) to Cisco Systems, Inc. (NasdaqGS: CSCO).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Splunk Inc. (NasdaqGS: SPLK) to Cisco Systems, Inc. (NasdaqGS: CSCO).
  • Under the terms of the proposed transaction, shareholders of Splunk will receive $157.00 in cash for each share of Splunk that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

Webex by Cisco Announces AI-Powered Solutions to Empower Contact Center Agent Potential and Reduce Burnout

Retrieved on: 
Thursday, October 26, 2023

ANAHEIM, Calif., Oct. 26, 2023  /PRNewswire/ -- Stress and burnout are common in the workplace, and even more so within contact center employees. In fact, a study found agent turnover is twice that of any other profession and that burnout causes 50% of agent turnover within contact centers. This costs businesses with 100 agents $4.8M each year on average. To combat this, Webex by Cisco (NASDAQ: CSCO), a leading provider of collaboration and contact center technologies powering hybrid work and customer experience, today announced new AI-powered capabilities in Webex Contact Center. These new capabilities aim to help improve agent well-being and productivity, resulting in exceptional customer experiences.

Key Points: 
  • Webex and Thrive Global deepen their partnership to solve customer service challenges with Thrive Reset integration into Webex Contact Center.
  • Thrive Reset for Webex Contact Center integrates well-being breaks into contact center agents' days using real-time insights from Webex, helping agents do their best work and reduce burnout.
  • In fact, a study found agent turnover is twice that of any other profession and that burnout causes 50% of agent turnover within contact centers.
  • To combat this, Webex by Cisco (NASDAQ: CSCO), a leading provider of collaboration and contact center technologies powering hybrid work and customer experience, today announced new AI-powered capabilities in Webex Contact Center.

Cisco Partners with NVIDIA to Unleash the Power of Hybrid Workspaces

Retrieved on: 
Wednesday, October 25, 2023

ANAHEIM, Calif., Oct. 25, 2023 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today unveiled the next milestone of its ongoing work with NVIDIA to deliver AI-powered meetings for hybrid workers. Cisco announced the launch of Room Kit EQX and the expansion of its Cinematic Meetings capabilities — both powered by NVIDIA's AI engine — with the goal of enhancing collaboration experiences with audio and video intelligence and enabling more equitable hybrid meetings.

Key Points: 
  • New Cisco portfolio of collaboration devices, powered by NVIDIA accelerated computing, offers customers the best collaboration experiences across a spectrum of workspaces.
  • ANAHEIM, Calif., Oct. 25, 2023 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today unveiled the next milestone of its ongoing work with NVIDIA to deliver AI-powered meetings for hybrid workers.
  • "Our collaboration with NVIDIA helps make this possible as we expand our portfolio of AI-powered solutions that unlock the potential of hybrid workers."
  • The integration of video devices supporting AI and machine learning is critical to ensuring the longevity of investments made to deliver hybrid work experiences.

Cisco Unveils Webex AI Strategy at WebexOne

Retrieved on: 
Wednesday, October 25, 2023

ANAHEIM, Calif., Oct. 25, 2023 /PRNewswire/ -- At WebexOne, Cisco (NASDAQ: CSCO) today announced a new AI strategy for Webex that will improve communication and collaboration. Unlike AI offerings that solely focus on text or documents, Webex will use real-time communications for audio and video to solve everyday challenges, such as ensuring crystal-clear audio and video calls and meetings despite low bandwidth. Today, Cisco also announced the launch of its new Webex AI Assistant with new capabilities that will bolster productivity and accuracy for customers. The Webex AI strategy and Webex AI Assistant will be applied across the full Webex portfolio — The Webex Suite, Cisco Collaboration devices, Webex Contact Center, Webex Connect and Webex Control Hub. Customers like McLaren Racing and Team DSM are testing Webex's new AI capabilities.

Key Points: 
  • ANAHEIM, Calif., Oct. 25, 2023 /PRNewswire/ -- At WebexOne, Cisco (NASDAQ: CSCO) today announced a new AI strategy for Webex that will improve communication and collaboration.
  • The Webex AI strategy and Webex AI Assistant will be applied across the full Webex portfolio — The Webex Suite, Cisco Collaboration devices, Webex Contact Center, Webex Connect and Webex Control Hub.
  • Webex AI Assistant is already natively integrated into Cisco Collaboration devices and will span the Webex portfolio.
  • The Webex AI strategy and Webex AI Assistant capabilities are secure and align with Cisco's Responsible AI Framework.

Cisco and Bang & Olufsen Unveil New Wireless Earbuds for Secure Hybrid Work

Retrieved on: 
Tuesday, October 24, 2023

ANAHEIM, Calif., Oct. 24, 2023 /PRNewswire/ -- Cisco (NASDAQ: CSCO) and Bang & Olufsen (CPH: BO) today unveiled new true wireless earbuds built with enterprise-grade features customized for professionals on-the-go. Furthering their partnership to provide customers with top-quality audio experiences whether they're at home, at work or in transit, the Bang & Olufsen Cisco 950 delivers a high-end aesthetic and premium sound combined with advanced security and manageability features.

Key Points: 
  • The new Bang & Olufsen Cisco 950 wireless earbuds are equipped with features critical for today's hybrid workforce, including enhanced security and device management for IT teams.
  • ANAHEIM, Calif., Oct. 24, 2023 /PRNewswire/ -- Cisco (NASDAQ: CSCO) and Bang & Olufsen (CPH: BO) today unveiled new true wireless earbuds built with enterprise-grade features customized for professionals on-the-go.
  • As hybrid work continues to enable flexibility in how and where people work, the Bang & Olufsen Cisco 950 enables crystal-clear audio for seamless collaboration from any setting.
  • "We're excited to expand our partnership with Cisco to deliver the Bang & Olufsen Cisco 950," said Duncan McCue, Vice President Business Development & Strategic Partnerships, Bang & Olufsen.

Generation Privacy: Younger Consumers Are 7 Times More Likely to Exercise their Data Rights, New Cisco Survey Shows

Retrieved on: 
Wednesday, October 18, 2023

Consumers are concerned about their privacy in relation to Artificial Intelligence: 60% have lost trust in organizations due to their AI use.

Key Points: 
  • Consumers are concerned about their privacy in relation to Artificial Intelligence: 60% have lost trust in organizations due to their AI use.
  • SAN JOSE, Calif., Oct. 18, 2023 /PRNewswire/ - Today, Cisco (NASDAQ: CSCO) published its 2023 Consumer Privacy Survey *, an annual global review of consumers' perceptions and behaviors on data privacy.
  • This year's survey highlights how younger consumers are taking deliberate action to protect their privacy, as 42% of consumers aged 18-24 exercise their Data Subject Access Rights, compared with just 6% for consumers 75 and older.
  • The survey also provides early insights on Generative AI (Gen AI), revealing that only 12% of respondents identify as regular users.

Generation Privacy: Younger Consumers Are 7 Times More Likely to Exercise their Data Rights, New Cisco Survey Shows

Retrieved on: 
Wednesday, October 18, 2023

Consumers are concerned about their privacy in relation to Artificial Intelligence: 60% have lost trust in organizations due to their AI use.

Key Points: 
  • Consumers are concerned about their privacy in relation to Artificial Intelligence: 60% have lost trust in organizations due to their AI use.
  • SAN JOSE, Calif., Oct. 18, 2023 /PRNewswire/ - Today, Cisco (NASDAQ: CSCO) published its 2023 Consumer Privacy Survey *, an annual global review of consumers' perceptions and behaviors on data privacy.
  • This year's survey highlights how younger consumers are taking deliberate action to protect their privacy, as 42% of consumers aged 18-24 exercise their Data Subject Access Rights, compared with just 6% for consumers 75 and older.
  • The survey also provides early insights on Generative AI (Gen AI), revealing that only 12% of respondents identify as regular users.

Blue Earth Diagnostics Ltd Collaborates with Sinotau Pharmaceutical Group to Bring Prostate Cancer PET Diagnostic Imaging Agent, Flotufolastat (18F) Injection, to China

Retrieved on: 
Tuesday, October 17, 2023

It marks an important stage in the Blue Earth Diagnostics’ strategy to make flotufolastat (18F) available to patients and clinicians globally.

Key Points: 
  • It marks an important stage in the Blue Earth Diagnostics’ strategy to make flotufolastat (18F) available to patients and clinicians globally.
  • Yanmin Tang, CEO of Sinotau Pharmaceutical Group, said, “Sinotau Pharmaceutical Group is dedicated to the field of new generation radiopharmaceuticals.
  • We are pleased to form this strategic cooperation with Blue Earth Diagnostics and we look forward to making flotufolastat (18F) available to the clinical community in China.
  • It is engineered to advance clinical decision-making by providing useful information to guide treatment planning in men with prostate cancer.

Alentis Therapeutics Appoints Lung Experts Professors Tony Mok and Steven Nathan to its Scientific Advisory Board

Retrieved on: 
Thursday, October 5, 2023

Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today the appointment of Tony Mok, Professor of Clinical Oncology at the Chinese University of Hong Kong and Steven Nathan, Professor at the University of Virginia as members of its Scientific Advisory Board.

Key Points: 
  • Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today the appointment of Tony Mok, Professor of Clinical Oncology at the Chinese University of Hong Kong and Steven Nathan, Professor at the University of Virginia as members of its Scientific Advisory Board.
  • View the full release here: https://www.businesswire.com/news/home/20231005193827/en/
    Lung experts Prof. Steven Nathan and Prof. Tony Mok join Alentis Therapeutics' Scientific Advisory Board.
  • (Photo: Alentis Therapeutics)
    “Tony and Steven have exceptional expertise in lung cancer and lung fibrosis, respectively, which will be of great value to our Scientific Advisory Board,” said Dr. Luigi Manenti, Chief Medical Officer of Alentis.
  • Prof. Steven Nathan is the Medical Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital and is a Professor at the University of Virginia.